NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹294 Cr | ₹225 Cr | ₹137 Cr | ₹64 Cr | ₹130 Cr |
What is the latest Capital Work in Progress ratio of NATCO PHARMA ?
| Year | Capital Work in Progress |
|---|---|
| Mar2026 | ₹294 Cr |
| Mar2025 | ₹225 Cr |
| Mar2024 | ₹137 Cr |
| Mar2023 | ₹64 Cr |
| Mar2022 | ₹130 Cr |
How is Capital Work in Progress of NATCO PHARMA Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2026 | ₹294 Cr | 30.30 | |
| Mar2025 | ₹225 Cr | 64.17 | |
| Mar2024 | ₹137 Cr | 113.53 | |
| Mar2023 | ₹64 Cr | -50.35 | |
| Mar2022 | ₹130 Cr | - | |
Compare Capital Work in Progress of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹14,831.3 Cr | 1.6% | -3.5% | -2.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,478.0 Cr | -0.2% | -3.2% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,031.0 Cr | 2% | 5.3% | 57.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,216.0 Cr | -2.4% | -3.1% | 36.4% | Stock Analytics | |
| CIPLA | ₹112,205.0 Cr | 0.6% | -2.2% | -9.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,040.0 Cr | 0.9% | 4% | -7.6% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 1.6% |
-3.5% |
-2.8% |
| SENSEX | -2.8% |
-6.1% |
-11.9% |
You may also like the below Video Courses